Related by context. All words. (Click for frequent words.) 71 meta analytic 71 methodological limitations 70 Meta analyzes 68 generalisability 68 residual confounding 67 randomized controlled trials RCTs 66 metaanalysis 66 convergent validity 66 methodological flaws 66 methodological 66 unmeasured confounders 65 Methodological 65 correlational 65 interobserver 65 generalizability 64 causal inference 64 methodological shortcomings 63 methodological weaknesses 63 Multiple logistic regression 63 Rigorous scientific 63 predictive validity 63 Sociodemographic 63 alexithymia 63 differential gene expression 62 ascertainment bias 62 nonpharmacologic 62 Subgroup analyzes 62 Reproducibility 62 cognitive affective 62 somatoform disorders 62 RCTs 62 histologic findings 62 dietary interventions 62 meta regression 61 psychometric properties 61 subgroup analyzes 61 Multivariate logistic regression 61 antioxidant supplementation 61 exploratory endpoints 61 histopathological 61 psychiatric comorbidity 61 pharmacodynamic parameters 61 biopsychosocial 61 nongenetic 61 neuroimaging studies 61 functional neuroimaging 61 inferential statistics 60 clinicopathological 60 bivariate analyzes 60 Observational studies 60 meta analyzes 60 prospective longitudinal 60 prostate carcinogenesis 60 multiple linear regression 60 electrophysiologic 60 fi ndings 60 Phenotypic 60 Heritability 60 neuroanatomical 60 multiple logistic regression 60 STEP BD 60 logistic regression analyzes 60 serum biomarkers 60 #F FDG PET 60 MDRD 60 psychopathological symptoms 59 Cytogenetic 59 generalisable 59 diagnosing ADHD 59 pathogenetic mechanisms 59 Histopathological 59 urodynamic 59 premorbid 59 IMPROVE HF 59 unmeasured factors 59 Poisson regression 59 preoperative diagnosis 59 quantifications 59 pathophysiological mechanisms 59 methodologically rigorous 59 pharmacological therapies 59 Echocardiographic 59 psychobiological 59 radiographic findings 59 etiologic 59 bivariate 59 neuropsychological impairments 59 unmeasured confounding 59 Systematic reviews 59 Randomized trials 59 empirically validated 59 plasma pharmacokinetics 59 poststroke depression 59 stepwise logistic regression 59 Longitudinal studies 59 surrogate markers 59 causal inferences 59 indications contraindications 59 interobserver reliability 58 pleiotropy 58 methodologically sound 58 selenium supplementation 58 biologic plausibility 58 neurosensory 58 neuropsychological assessment 58 covariate 58 microbiologic 58 neurodevelopmental outcome 58 perinatal outcomes 58 etiological 58 immunological responses 58 multivariate analyzes 58 neurocognitive functioning 58 neurophysiologic 58 pathophysiological 58 neuropathological 58 probiotic supplementation 58 immunohistochemical 58 chi squared 58 HRQL 58 Histologic 58 methodological rigor 58 cytologic 58 clinico pathological 58 oncologic outcomes 58 prenatal exposures 58 Francesca Bravi 58 pharmacologic treatments 58 BEXXAR Therapeutic Regimen 58 biochemical abnormalities 58 chromosomal anomalies 58 psychotherapies 58 chemoprevention trials 58 univariate 58 confounder 58 hypochondriasis 58 HIV tropism 58 prognostic indicators 57 aetiological 57 emotional dysregulation 57 periprocedural MI 57 Coronary CTA 57 Bonferroni 57 clinicopathologic 57 plasma lipid 57 enzyme immunoassay EIA 57 intraobserver 57 immunotoxicity 57 nutrient supplementation 57 Genetic predisposition 57 metabolite concentrations 57 developmental neurotoxicity 57 Comorbidities 57 pairwise comparisons 57 Bonferroni correction 57 Cardiotoxicity 57 Multivariable logistic regression 57 Alan Dangour 57 nonadherence 57 IPCC TAR 57 aetiology 57 parasitological 57 microstructural 57 interrater reliability 57 perseverative 57 genotype phenotype 57 Randomised controlled trials 57 toxicologic 57 somatoform disorder 57 Pharmacologic 57 ecotoxicological 57 conditional logistic regression 57 epidemiologic studies 57 ConclusionThis 57 transcriptomic 57 underlying molecular mechanisms 57 Histopathologic 57 Descriptive statistics 57 methodological differences 57 underlying pathophysiology 57 histopathological examination 57 pharmacological interventions 57 antidepressant efficacy 57 Uncorrected 57 fetal malformations 57 pure fructose 57 Secondary efficacy endpoints 57 Cognitive impairment 57 APOE genotype 57 mean ± SEM 57 psychosocial functioning 57 mechanistic studies 57 Univariate 57 histopathologic 57 Multiple linear regression 57 acetabular fractures 57 autonomic dysfunction 57 generalized estimating 56 myocardial viability 56 riociguat 56 hypersensitivity allergic reactions 56 Symptom severity 56 Cochrane reviewers 56 stone formers 56 nomograms 56 mammographic density 56 prospective observational studies 56 ultrastructural 56 neurodevelopmental outcomes 56 #:#-# [029] 56 underdiagnosis 56 CYP #D# 56 immunohistochemical analysis 56 Clinical Outcome 56 Socio demographic 56 psychosocial stressors 56 BPS IC 56 thiopurine 56 bronchopulmonary dysplasia BPD 56 biological plausibility 56 guideline concordant 56 univariate analyzes 56 Cardiorespiratory fitness 56 syndromal 56 Randomized controlled 56 genomewide 56 genotypic 56 Electrophysiological 56 psychopharmacological 56 adjuvant therapies 56 HER2 expression 56 nosology 56 neurobehavioural 56 F FDG PET 56 NICE SUGAR 56 developmental trajectories 56 noncognitive 56 dose proportionality 56 fetal chromosomal 56 bivariate analysis 56 physico chemical properties 56 probabilistic reasoning 56 infantile colic 56 etiological factors 56 pituitary hormone 56 CAM modalities 56 physicochemical 56 follicular adenoma 56 Morphological 56 pharmacoeconomic 56 hematologic parameters 56 genotypic resistance 56 endophenotypes 56 oncological outcomes 56 STRIDE PD 56 Deutsches Arzteblatt International 56 neurobiological mechanisms 56 psychosocial variables 56 Intervention Effectiveness CATIE 56 LVNC 56 microdeletion 56 authors hypothesized 56 ECLS 56 multivariable analysis 56 causal pathways 56 somatic symptoms 56 Clinical Antipsychotic Trials 56 Neurocognitive 56 nonrandomized studies 56 physiologic mechanisms 56 Zevalin consolidation 56 Pharmacodynamic 56 familial aggregation 56 functional gastrointestinal disorders 56 antiphospholipid syndrome 56 Lancet Neurology journal 56 multivariate regression analysis 56 vertebral subluxation 56 CPAP adherence 55 Clinical Relevance 55 discriminant 55 haematologic 55 phthalate exposure 55 artifactual 55 reliabilities 55 adjuvant systemic 55 nonparametric 55 thimerosal exposure 55 dosimetric 55 mitochondrial metabolism 55 CT urography 55 Kaplan Meier curve 55 pleiotropic effects 55 cardiac autonomic 55 physico chemical 55 Comorbid 55 microarray gene expression 55 imply causality 55 vitamin D inadequacy 55 geomorphological 55 syndromic 55 hyperactivity inattention 55 antitumor efficacy 55 nanoparticle toxicity 55 genetic loci 55 bone scintigraphy 55 EEG abnormalities 55 quasispecies 55 perioperative morbidity 55 pharmacodynamic markers 55 cognitive behavioral therapies 55 scintigraphic 55 somatization disorder 55 Socioeconomic status 55 Outpatient Setting 55 multivariate logistic regression 55 neuropathologic 55 comorbid psychiatric disorders 55 bile acid metabolism 55 IGRAs 55 cranial irradiation 55 journal Neuropsychology 55 PREVENT IV 55 mechanistic explanation 55 compulsive hoarding syndrome 55 Cognitive behavioral 55 variance ANOVA 55 Dtsch Arztebl Int 55 hematopoietic malignancies 55 interrater 55 genetic polymorphism 55 subscale scores 55 orofacial clefts 55 neuritic 55 Sensitivity analyzes 55 bone metabolism 55 analogical reasoning 55 dimensional sonography 55 motor neuron degeneration 55 Neuropsychologia 55 Biochemical Zoology 55 explanatory variables 55 retrospective observational 55 Bayesian inference 55 neurocognition 55 echocardiographic parameters 55 recurrent miscarriage 55 pharmacological approaches 55 affective disorders 55 journal BJU International 55 transient elastography 55 Mechanistic 55 diffusion tensor 55 primary aldosteronism 55 neuro developmental 55 ROC curves 55 Histological 55 bibliometrics 55 serotonin deficiency 55 metabonomics 55 methodological approaches 55 prognostic variables 55 serum folate concentrations 55 Prof. Krainer 55 Haplotype 55 neuropsychological impairment 55 chromosomal rearrangement 55 confounding variables 55 somatic mutations 55 teratogenicity 55 differential diagnoses 55 biostatistical analysis 55 esophageal reflux 55 genetic polymorphisms 55 sociodemographic characteristics 55 Multivariate analysis 55 Prefrontal 55 radiographic outcomes 55 antenatal depression 55 NHAMCS 55 urodynamic studies 55 genomic alterations 55 microRNA profiling 55 meta analytic review 55 Subgroup analysis 55 BCL#A 55 biopsychosocial model 55 venous thromboembolic disease 55 neurocognitive deficits 55 AST ALT 55 CONSORT 54 detect XMRV 54 atherothrombotic 54 maturational 54 urodynamic parameters 54 probabilistic modeling 54 #q# deletion syndrome 54 interpretational 54 Serologic 54 pharmacogenetic testing 54 Primary endpoints 54 multicenter trials 54 Navas Acien 54 journal Resuscitation 54 prognostically 54 Cronbach alpha 54 nonrandomized 54 histologic subtypes 54 hamartomas 54 familial clustering 54 Heterogeneity 54 logistic regression models 54 undiagnosed celiac disease 54 Hypotheses 54 metacognitive 54 ACCORD Lipid 54 VADT 54 null hypothesis 54 allele frequencies 54 Clinical Gastroenterology 54 environmental toxicants 54 testosterone supplementation 54 placebo controlled studies 54 NSQIP 54 CSF biomarkers 54 nonsampling errors 54 CORE OM 54 intraclass correlation coefficients 54 pharmacodynamic endpoints 54 histologic examination 54 sonographic diagnosis 54 antibiotic regimens 54 anthropometric measures 54 sociologic 54 micronutrient intake 54 intestinal permeability 54 non pharmacological interventions 54 Post hoc 54 EMPOWER TM 54 stochastic resonance 54 Comparative effectiveness 54 observational studies 54 posttest 54 PROactive study 54 modifier genes 54 regression equations 54 biobehavioral 54 serum BDNF 54 multivariate Cox 54 tumor subtype 54 neuromotor 54 mtDNA mutations 54 PM#.# exposure 54 neurocognitive function 54 autism researcher Irva 54 Immunologic 54 nucleosome positioning 54 chest radiographs 54 diabetic polyneuropathy 54 modifiable lifestyle 54 neuropsychiatric diseases 54 metabolic parameters 54 STAT3 signaling 54 multivariable Cox 54 psychodynamic therapy 54 spirometric 54 phylogenetic relationships 54 CLBP 54 inflammatory biomarkers 54 Genetic variation 54 bazedoxifene conjugated estrogens 54 stereochemical 54 left ventricular diastolic 54 sonographic findings 54 epistasis 54 myocardial dysfunction 54 quantitative reasoning 54 retest reliability 54 IQWiG 54 cis regulatory 54 Vertos II 54 Vauthey 54 extramedullary 54 corneal thickness 54 semiquantitative 54 KRAS variant 54 thromboembolic disease 54 intelligence quotient IQ 54 Eur Urol 54 preterm newborns 54 de novo mutations 54 hematopoietic cancers 54 steroidogenic 54 multifactorial 54 Logistic regression 54 journal Physiological 54 meta analysis 54 neuropsychiatric symptoms 54 incidentalomas 54 pathophysiologic 54 randomized controlled trials 54 mortality morbidity 54 Patellofemoral 54 DNA methylation patterns 54 mechanistic insights 54 HRQOL 54 Univariate analysis 54 silent myocardial ischemia 54 haematological 54 psychopathological 54 tumorigenicity 54 multivariate regression 54 histologic 54 choline intake 54 cerebral oxygenation 54 neurologic abnormalities 54 antiplatelet therapies 54 Tumor Response 54 perioperative complications 54 AVERROES 54 STICH trial 54 ANOVA 54 treatability 53 serum lipid 53 neurobiological basis 53 intracranial stenosis 53 journal CHEST 53 adrenal function 53 FGFR2 gene 53 Systematic Review 53 connective tissue diseases 53 Mantel Haenszel 53 sociodemographic factors 53 Extrinsic 53 SYNTAX trial 53 neuropsychological deficits 53 classificatory 53 socioeconomic variables 53 preclinical pharmacokinetic 53 Arch Surg 53 persistency mortality 53 Nature Reviews Neuroscience 53 phenotypic variation 53 attain statistical significance 53 psychiatric morbidity 53 testicular dysgenesis syndrome 53 Randomized Controlled Trials 53 phylogeographic 53 evolvability 53 cardiometabolic risk 53 Neuropsychological 53 affective psychoses 53 virological 53 G6PD deficiency 53 cerebellar vermis 53 allogeneic HCT 53 anthropometric measurements 53 theoretical frameworks 53 N glycan 53 Confirmatory 53 Analytical Method 53 bioenergetic 53 renal biopsy 53 gastric carcinoma 53 Prognostic Factors 53 veridical 53 chemosensitivity 53 QSAR models 53 intestinal biopsy 53 CYP#C# gene 53 reboxetine 53 preimplantation genetic screening 53 symptomology 53 K ras mutations 53 cosmological models 53 preoperative MRI 53 karyotypes 53 vasogenic edema 53 conventional angiography 53 stratifying patients 53 journal Pharmacotherapy 53 psychophysiological 53 medicine EBM 53 postmarketing surveillance 53 SF #v# 53 multivariable adjusted 53 amygdala reactivity 53 Buhimschi 53 Singh Manoux 53 thyrotropin 53 phospholipid membranes 53 ABL1 53 revision hip arthroplasty 53 journal Psychological Bulletin 53 pathophysiological processes 53 varus deformity 53 urolithiasis 53 chronicity 53 somatization 53 interindividual variability 53 Digital Mammographic Imaging 53 hyperhomocysteinemia 53 retrospective cohort 53 endocrine disruption 53 antipsychotic prescribing 53 apolipoproteins 53 cytological 53 DHEA supplementation 53 genotoxicity 53 Rh incompatibility 53 Non inferiority 53 prognostic markers 53 Child Behavior Checklist 53 intact parathyroid hormone 53 serologic testing 53 chromium picolinate supplementation 53 infantile amnesia 53 Genetic Variation 53 erection hardness 53 Correlative 53 Intervention Trial 53 topical NSAIDs 53 mitochondrial toxicity 53 posttreatment 53 immunofluorescent 53 abnormal glucose tolerance 53 synthetic lethality 53 antiepileptics 53 prognostic significance 53 methodologically 53 Depressive symptoms 53 homocysteine concentrations 53 cardiac malformations 53 noncardiac 53 intestinal motility 53 serum leptin 53 Dickersin 53 NP CRNs 53 distributional impacts 53 neurocognitive impairment 53 coexpression 53 viral etiology 53 pharmacokinetic interaction 53 aldosterone antagonist 53 CYP#D# gene 53 prostate cancer CaP 53 SNP rs# [002] 53 Predisposition 53 IPCC AR4 53 routine episiotomy 53 multivariate statistical 53 serum vitamin D 53 Immunohistochemical 53 colonoscopic 53 aminotransferase 53 rheological 53 depressive symptom 53 body habitus 53 sperm morphology 53 thyroid dysfunction 53 airway responsiveness 53 pharmacokinetic PK 53 cerebral ischemia 53 miRs 53 imatinib resistance 53 vascular endothelial dysfunction 53 eculizumab therapy 53 Brief Psychiatric 53 Systematic Reviews 53 lithological controls 53 postmenopausal estrogen 53 primary dysmenorrhoea 53 varicoceles 53 prospective multicentre 53 chronic LBP 53 PIB PET 53 C1q 53 immunological mechanisms 53 beta1 integrin 53 observational cohort 53 demonstrated clinically meaningful 53 multivitamin supplementation 53 Reproducible 53 genetic susceptibilities 53 allergenicity 53 x ray crystallographic 53 MTHFD1L gene 53 limb sparing 53 bone marrow fibrosis 53 HAM D# 53 Microstructural 53 CNTNAP2 53 lymphocyte activation 53 SLNB 53 Quantification 53 Pharmacokinetic PK 53 MDRD equation 53 potentially modifiable 53 electroencephalographic 53 Predictive Toxicology 53 ALI ARDS 53 percutaneous vertebroplasty 53 clinicopathological features 52 neurobiological underpinnings 52 journal Ophthalmology 52 Cystatin C 52 Myerburg 52 dietary antioxidants 52 Mechanistic studies 52 amisulpride 52 differentially expressed genes 52 SpHb monitoring 52 nucleotide substitutions 52 scientifically testable 52 plain radiographs 52 HIV HCV coinfected 52 perfusion abnormalities 52 allelic 52 neural substrates 52 heritable variation 52 EBUS FNA 52 nodal metastases 52 journal Palaios 52 renal allograft 52 longitudinal cohort study 52 carotid angioplasty 52 mTOR inhibition 52 chronic prostatitis chronic 52 laterality 52 colorectal carcinogenesis 52 morphologic 52 Human Reproduction journal 52 biostatistical 52 IUGR 52 psychotherapeutic interventions 52 allelic variation 52 #:#-# [035] 52 prospective multicenter study 52 trials RCTs 52 pathologic examination 52 aneuploidy screening 52 NEUVENGE 52 CHAMPION PCI 52 abdominal adiposity 52 myocardial ischaemia 52 Shamay Tsoory 52 DSM IV diagnoses 52 symptomatology 52 histopathologic examination 52 clinically insignificant 52 postoperative AF 52 immunohistochemical staining 52 neuro developmental disorders 52 limiting generalizability 52 GERD migraine headaches 52 cerebral oximetry 52 metabolic dysfunction 52 atherogenesis 52 antiangiogenic agents 52 abiotic stresses 52 semistructured interviews 52 color Doppler sonography 52 transabdominal 52 EQ 5D 52 subthreshold depression 52 plasma homocysteine 52 Socioeconomic factors 52 Noncritical 52 Bioavailability 52 prenatal phthalate exposure 52 Appropriateness Criteria 52 vertebrate embryos 52 FUS protein 52 Cochrane Database 52 androgen depletion 52 psychiatric comorbidities 52 Mathematical modeling 52 Carotid Endarterectomy 52 nutrigenomic 52 PLCO 52 precaution Wiehle 52 Catheter Associated 52 d dimer 52 glial tumors 52 interpersonal psychotherapy 52 Comorbidity 52 beta carotene supplementation 52 hepatic enzyme 52 Hallux valgus 52 ExTRACT TIMI 52 Clinical Psychology Review 52 covariance ANCOVA 52 facial clefts 52 transvaginal sonography 52 inter rater reliability 52 thrombophilia 52 nutrient intakes 52 cAMP signaling 52 TMPRSS2 ERG fusion 52 postapproval 52 adverse perinatal 52 intentional concealment 52 glutamate glutamine 52 enterotypes 52 logistic regressions 52 methodologically flawed 52 Androgen 52 ELISPOT 52 fibrotic disease 52 immunodeficiencies 52 immunostimulatory effects 52 CHD mortality 52 teratogenic 52 missense mutations 52 GABAergic interneurons 52 morphometrics 52 virologic responses 52 Sociocultural 52 gonococcal 52 behavioral disinhibition 52 thyrotropin levels 52 FDG PET imaging 52 Hematological 52 Am J Cardiol 52 Psychosomatic Research 52 Nonspecific 52 rhinovirus infection 52 genomic biomarker 52 HYVET 52 haemodynamic 52 SGAs 52 rEEG 52 histopathologic diagnosis 52 pharmacokinetic characteristics 52 See CLINICAL PHARMACOLOGY 52 Evidentiary 52 P. falciparum parasites 52 Logistic regression analysis 52 RQ PCR 52 induced sputum 52 pharmacotherapeutics 52 KRAS mutation status 52 logistic regression 52 hip resurfacing arthroplasty 52 Liver Fibrosis 52 interobserver variability 52 etiologies 52 regression analyzes 52 clefting 52 borderline statistical significance 52 anhedonia 52 comorbid conditions 52 EGFR expression 52 HDL Selective Delipidation 52 Antigenic 52 #:#-# [033] 52 Goldbourt 52 elevated homocysteine 52 serological 52 serological tests 52 overbreadth 52 sonographically guided 52 indicates cardio circulatory 52 thermodynamic modeling 52 testable theories 52 pathophysiologic mechanisms 52 osteocalcin protein 52 Nonclinical 52 metabolomic profiling 52 Functional neuroimaging 52 platelet activation 52 medically unexplained 52 MAQC 52 subclinical atherosclerosis 52 dietary folate 52 pretransplant 52 symptomatic VTE 52 Bayes theorem 52 recurrent headaches 52 vascular dysfunction 52 etiologic factors 52 ELBW infants 52 androgen depletion therapy 52 Hepatotoxicity 52 underestimations 52 BRCA testing 52 objectively verifiable 52 dose Iluvien 52 Dr. Bezprozvanny 52 prospectively defined 52 metabolic syndrome MetS 52 ROCKET AF 52 morphometric vertebral fractures 52 hepatic fibrosis 52 sacral neuromodulation 52 Pre Exposure Prophylaxis 52 Pearson correlation coefficients 52 genomewide association study 52 Symptom Checklist 52 Reynolds Risk Score 52 Dr Chavarro 52 neo Darwinism 52 bronchial responsiveness 52 cardiometabolic syndrome 52 bone marrow mesenchymal stem 52 Alpha Tocopherol Beta Carotene 52 CARE HF 52 immunomodulation 52 esophageal motility 52 embryo biopsy 52 KRAS status 52 scientifically invalid 52 proteomic analysis 52 Toxicological 52 DNA demethylation 52 islet isolation 52 Kruskal Wallis test 52 neonatal morbidity 52 Randomized clinical trials 52 esophageal carcinoma 52 NRF2 gene 52 monozygotic twins 52 tissue perfusion 52 acute subacute 52 comorbid disorders 52 SRBD 52 hole NFX# 52 journal Anesthesiology 52 immunochemical fecal occult 52 electromechanical coupling 52 carotid IMT 52 monogenic 52 protein conformation 52 impaired cognition 52 regression coefficients 52 nondemented 52 intracranial hypertension 52 neurocognitive outcomes 52 elevated ALT 52 medical journal Thorax 52 Functional Outcomes 52 dietary acrylamide 52 optimality 52 SCK difficulty 52 Immunohistochemistry 52 radiographic evaluation 52 generalized linear 52 Assisted reproduction 52 ultrasonographic 52 endocrinologic 52 Meta Analyses 51 Informed consent 51 pulp metallic 51 Generalized Anxiety Disorder 51 SOCE 51 Biomacromolecules 51 empirical observation 51 NeuroImage 51 Bayesian methods 51 efficacy tolerability 51 DHA supplementation 51 pathophysiologic mechanism 51 VLBW 51 genomic biomarkers 51 cystic fibrosis chronic pancreatitis 51 thromboprophylaxis 51 Lactobacillus GG 51 viral kinetics 51 Epidemiologic 51 non selective NSAIDs 51 Gad Getz 51 hippocampal function 51 macrovascular events 51 Shlipak 51 periodontal tissues 51 paralogs 51 morphological traits 51 lymphocyte proliferation 51 serum lipid levels 51 transcriptomics 51 Cockcroft Gault 51 PCWP 51 microsatellite instability 51 cardioprotective effects 51 prospective observational cohort 51 overactive bladder symptoms 51 CP CPPS 51 MEND CABG 51 anatomical physiological 51 CT perfusion 51 Diagnostic Criteria 51 metabolic alterations 51 thyroglobulin 51 psychometrically sound 51 hypercoagulable 51 genomewide association studies 51 asplenia 51 Adverse effects 51 charts graphs tables